Adhesive RAFT agents for controlled polymerization of acrylamide: effect of catechol-end R groups

Olabode O. Oyeneye, William Z. Xu and Paul A. Charpentier*
Department of Chemical and Biochemical Engineering, University of Western Ontario, London, ON N6A 5B9, Canada. E-mail: pcharpentier@eng.uwo.ca

Received 11th August 2015 , Accepted 28th August 2015

First published on 28th August 2015


Abstract

Synthesizing polyacrylamide (PAM) inorganic nanocomposites with stable tethering and controlled polymer length has been elusive. Herein, we report on the synthesis of trithiocarbonates with several catechol end R groups (as anchors) that differ in their carbonyl α-substituents. These so-called adhesive RAFT agents were subsequently examined in batch RAFT polymerization of the acrylamide (AM) monomer to study their living characteristics. The catechol-end trithocarbonates (Dopa-CTAs) and catechol-end PAM structures (≤46 kDa) were confirmed via 1D (1H and 13C) and 2D (gHSQC, gHMBC) NMR. Subsequent anchoring of the end-functionalized PAM (grafting to) via catechol induced linkage to γ-alumina nanoparticles was successful, giving good correlation based on ATR-FTIR, DLS and TGA analyses. This unique methodology enables PAM-inorganic nanocomposites to be synthesized with stable tethering without significant rate retardation.


Introduction

Polymeric inorganic nanocomposites (PNCs) using so-called “smart” (co)polymers1–4 have shown potential by harnessing the synergic effects of both the polymer and inorganic components to enhance the properties for end-use applications such as water treatment flocculation.5–7 To link the polymer component to the inorganic nanoparticles, various coupling molecules have been investigated including carboxyls,8 catechol derivatives,9–13 phosph(on)ates,14 silanes,15–17 and thiols.18–20 Catechol derivatives have been shown to provide strong and stable chemisorption bonding between the polymer component and inorganic nanoparticles.11–13 To provide this catechol functionality, dopamine is bifunctional with an amine moiety that can be chemically modified for amide linkage formation to polymer, while the catechol will promote mono- or bi-dentate bonding to the inorganic nanoparticles (NPs).21,22

Strategies commonly used for the synthesis of pre-defined PNCs involve controlled radical polymerization (CRP) using either “grafting from” or “grafting to” approaches, with the latter entailing the immobilization of end-functionalized polymer on NPs. The inorganic NPs being the core help to define the final morphology of the PNC, in conjunction with controlled polymerization to ensure uniform extension of the polymeric chains from the NP core. Of the CRP techniques, the reversible addition–fragmentation chain transfer (RAFT) polymerization method has been given immense attention for the synthesis of advanced materials. This is because of its potential for tailored materials with predetermined molecular weight (MW), complex architectures, diverse functionalities and narrow dispersity (Đ).23 In particular, the RAFT polymerization technique has been shown to possess advantages over both ATRP and nitroxide techniques because of the ease of implementation and the wide range of applicable monomers (functional and non-functional), solvents and conditions. Under the “grafting to” approach, end-functionalized polymers can be prepared utilizing a RAFT agent (ZC([double bond, length as m-dash]S)SR) that has a Z- or R-substituent bearing the required end-group.8,24 However, selection of the substituents needs to be suited for the specific monomer, as they influence the RAFT agent reactivity, solubility and polymerization kinetics.25 Among the various classes of RAFT agents, trithiocarbonates are more hydrolytically stable and offer better control over polymer structure derived from more activated monomers, such as acrylamide.26

A number of studies have utilized a catechol moiety (as an adhesive molecule) with RAFT polymerization techniques for PNC syntheses, and catechol end-functionalization of polymers is often achieved in situ using catechol bearing RAFT agents for polymerization13,27 or after polymer synthesis via post-modification.28,29 However, to the best of our knowledge, no studies have attempted to compare catechol bearing RAFT agents having differing substituents at their alpha positions for the most suited livingness characteristics with respect to monomers. Herein, we investigate the influence of trithiocarbonate RAFT agents bearing the same Z group but different catechol end R groups on acrylamide (AM) polymerization, and subsequent anchoring of the resulting polymer to γ-alumina NPs. More specifically, the catechol RAFT agents differ in the substituents on their trithiocarbonate α carbon, and one of the RAFT agents being more bulky (see Scheme 1). The catechol end R group affects the partitioning of intermediate radicals, and should be a good homolytic leaving group for preferential partitioning into new radical species (derived from the R-group) which are capable of efficient re-initiation.30,31 We focused on end-functionalized polymers for subsequent “grafting to” as opposed to surface-initiated polymerization, because dense anchoring of the catechol-end CTA on metal oxide NPs requires conditions that cause hydrolytic decomposition of trithiocarbonate groups.10,32 The AM monomer was chosen because of the wide utility of PAM in applications as flocculants or additives in wastewater treatment,5,33,34 while γ-Al2O3 was employed because of its high OH density, high surface activity and propensity for wastewater treatment.35,36


image file: c5ra16193b-s1.tif
Scheme 1 End-functionalization of polyacrylamide with RAFT agents possessing different catechol-end R groups.

Experimental section

Materials

γ-Alumina dTEM ≤ 50 nm, surface area > 40 m2 g−1 (BET), acrylamide (AM, ≥98%), 4,4′-azobis(4-cyanovaleric acid) (ACVA, ≥98%), dopamine hydrochloride, N-hydroxysuccinimide (NHS, 98%), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, ≥98%), sodium chloride (NaCl, ≥99%), 2-(dodecylthiocarbonothioylthio)-2-methylpropionic acid (DDMAT, 98%), 2-(dodecylthiocarbonothioylthio)propionic acid (DoPAT, 97%), 4-cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic acid (CDSPA, 97%) and methanol (MeOH, ≥99.9%) were purchased from Sigma Aldrich, Canada and used as received. All other organic solvents used were the highest purity available from the Caledon Laboratory Ltd, Canada. Sodium bicarbonate (NaHCO3, ≥95%), anhydrous sodium sulfate (Na2SO4, ≥99%) and anhydrous magnesium sulfate (MgSO4) and sulfuric acid (96.5%) were obtained from the Caledon Labs (CA). Triethylamine (Et3N, 99.5%) and hydrogen peroxide (30.5%) were procured from EDM Chemicals (USA). Dialysis membranes (MW 3500 Da) were purchased from Spectrum Laboratories, Inc., while 25 μm filters (Fischer Scientific) were obtained from VWR Canada. All batch polymerization reactions were previously purged under argon atmosphere (ultra-high purity, Praxair Inc. Canada).

Characterization

A brief and detailed description of the characterization methods can be found in the ESI.

Synthesis of RAFT agents with (2,5-dioxopyrrolidin-1-yl)oxidanyl end groups (Suc-CTAs, (2a–c))

The synthesis of Suc-CTAs was performed based on a literature method13 by varying R groups while using a simplified workup procedure. NHS (0.40 g, 3.40 mmol) and EDC (0.76 g, 3.43 mmol) were added to 2.68 mmol each of CDSPA, DDMAT, and DoPAT dissolved in dried DCM (30 mL, previously dried with anhydrous Na2SO4), and allowed to react for 18 h under continuous stirring at room temperature. Each reaction mixture was then washed with 150 mL of saturated NaHCO3 (aq.) before collecting the DCM phase. Further extraction from the aqueous phase was carried out with ethyl ether (5 × 30 mL), and then combined with the DCM phase to give a single organic phase, which was washed with deionized water (3 × 50 mL), brine (3 × 50 mL) and dried over anhydrous MgSO4 (7.0 g). The hydrated MgSO4 was filtered off and the solvent removed using a Rotavap to obtain yellowish solid products.
Suc-DDMAT. 1H NMR (600 MHz, CDCl3) δ (ppm): 0.89 (t, J = 7.0 Hz, 3H, CH3CH2CH2), 1.23–1.34 (m, 16H, CH3(CH2)8CH2), 1.36–1.42 (m, 2H, CH2(CH2)2S), 1.66–1.72 (m, 2H, CH2CH2S), 1.88 (s, 6H, C(CH3)2), 2.82 (m, 4H, (O[double bond, length as m-dash])C(CH2)2C([double bond, length as m-dash]O)), 3.31 (t, J = 7.0 Hz, 2H, CH2S); 13C NMR (100 MHz, CDCl3) δ (ppm): 14.1 (CH3CH2CH2), 22.7 (CH3CH2CH2), 25.6 (C(CH3)2, (O[double bond, length as m-dash])C(CH2)2C([double bond, length as m-dash]O)), 27.8 (CH2CH2S), 29.0 (CH2(CH2)2S), 29.1 (CH2(CH2)3S), 29.3 (CH2(CH2)4S), 29.4 (CH3(CH2)2CH2), 29.5 (CH3(CH2)3CH2), 29.6 (CH3(CH2)4(CH2)2), 31.9 (CH3CH2CH2), 37.2 (CH2CH2S), 54.3 (C(CH3)2), 168.6 (N(C[double bond, length as m-dash]O)2), 169.1 (C([double bond, length as m-dash]O)O), 218.7 (SC([double bond, length as m-dash]S)S). FTIR (cm−1): 2916 (νasCH2), 2847 (νsCH2), 1777 (νC[double bond, length as m-dash]O, imide), 1734 (νC[double bond, length as m-dash]O, ester), 1202 (νC–O, ester), 1073 (νC[double bond, length as m-dash]S), 811 (νasS–C–S).
Suc-DoPAT. 1H NMR (600 MHz, CDCl3) δ (ppm): 0.88 (t, J = 7.0 Hz, 3H, CH3CH2CH2), 1.22–1.33 (m, 16H, CH3(CH2)8CH2), 1.39 (quin, J = 7.2 Hz, 2H, CH2(CH2)2S), 1.62–1.73 (m, 2H, CH2CH2S), 1.75 (d, J = 7.4 Hz, 3H, CH(CH3)), 2.83 (br. s, 4H, (O[double bond, length as m-dash])C(CH2)2C([double bond, length as m-dash]O)), 3.37 (td, J = 7.4 Hz × 2 and 3.1 Hz, 2H, CH2S), 5.14 (q, J = 7.4 Hz, 1H, CH(CH3)); 13C NMR (100 MHz, CDCl3) δ (ppm): 14.1 (CH3CH2CH2), 16.7 (CH(CH3)), 22.6 (CH3CH2CH2), 25.6 ((O[double bond, length as m-dash])C(CH2)2C([double bond, length as m-dash]O)), 27.8 (CH2CH2S), 28.9 (CH2(CH2)2S), 29.0 (CH2(CH2)3S), 29.3 (CH2(CH2)4S), 29.4 (CH3(CH2)2CH2), 29.5 (CH3(CH2)3CH2), 29.6 (CH3(CH2)4(CH2)2), 31.9 (CH3CH2CH2), 37.5 (CH2CH2S), 45.0 (CH(CH3)), 167.2 (N(C[double bond, length as m-dash]O)2), 168.5 (C([double bond, length as m-dash]O)O), 220.2 (SC([double bond, length as m-dash]S)S). FTIR (cm−1): 2914 (νasCH2), 2848 (νsCH2), 1786 (νC[double bond, length as m-dash]O, imide), 1736 (νC[double bond, length as m-dash]O, ester), 1471, 1358, 1200 (νC–O, ester), 1073 (νC[double bond, length as m-dash]S), 813 (νasS–C–S).
Suc-CDSPA. 1H NMR (600 MHz, CDCl3) δ (ppm): 0.89 (t, J = 7.0 Hz, 3H, CH3CH2CH2), 1.23–1.33 (m, 16H, CH3(CH2)8CH2), 1.35–1.44 (m, 2H, CH2(CH2)2S), 1.66–1.73 (m, 2H, CH2CH2S), 1.89 (s, 3H, C(CH3)), 2.48–2.69 (m, 2H, CH2CH2C([double bond, length as m-dash]O)O), 2.85 (br. s, 4H, (O[double bond, length as m-dash])C(CH2)2C([double bond, length as m-dash]O)), 2.94 (ddd, J = 10.0, 6.2, 3.8 Hz, 2H, CH2C([double bond, length as m-dash]O)O), 3.34 (t, J = 7.3 Hz, 2H, CH2CH2S); 13C NMR (100 MHz, CDCl3) δ (ppm): 14.1 (CH3CH2CH2), 22.7 (CH3CH2CH2), 24.8 (C(CH3)), 25.6 ((O[double bond, length as m-dash])C(CH2)2C([double bond, length as m-dash]O)), 26.8 (CH2C([double bond, length as m-dash]O)O), 27.6 (CH2CH2S), 28.9 (CH2(CH2)2S), 29.0 (CH2(CH2)3S), 29.3 (CH2(CH2)4S), 29.4 (CH3(CH2)2CH2), 29.5 (CH3(CH2)3CH2), 29.6 (CH3(CH2)4(CH2)2), 31.9 (CH3CH2CH2), 33.2 (CH2CH2C([double bond, length as m-dash]O)O), 37.1 (CH2CH2S), 46.0 ((CH3)C(C[triple bond, length as m-dash]N)), 118.6 (C(C[triple bond, length as m-dash]N)), 167.0 (C([double bond, length as m-dash]O)O), 168.8 (N(C[double bond, length as m-dash]O)2), 216.5 (SC([double bond, length as m-dash]S)S). FTIR (cm−1): 2916 (νasCH2), 2848 (νsCH2), 2235 (νC[triple bond, length as m-dash]N), 1820, 1783 (νC[double bond, length as m-dash]O, imide), 1734 (νC[double bond, length as m-dash]O, ester), 1423, 1383, 1293, 1199 (νC–O, ester), 1066 (νC[double bond, length as m-dash]S), 884, 803 (νasS–C–S).

Synthesis of catechol end group CTAs (Dopa-CTAs (3a–c))

Typically, dopamine hydrochloride (0.50 g, 2.64 mmol) and each of Suc-CDSPA, Suc-DDMAT and Suc-DoPAT (2.13 mmol) were added to MeOH (30 mL) with Et3N (0.40 mL, 2.87 mmol), and allowed to undergo dark reaction for 48 h at room temperature under continuous stirring. At the end of the reaction, the solvent was removed by rotary evaporation, followed by the addition of ether (20 mL) and washing of the aqueous phase. Subsequently, the ether phase was washed with deionized water (3 × 15 mL) and brine (3 × 15 mL). The ether solvent was removed by vacuum evaporation, and then the viscous solute cooled (4 °C) before precipitating in hexane (except for Dopa-CDSPA) to give a bright yellow solid product, which was vacuum dried. In the case of Dopa-CDSPA, further purification was carried out via preparative column chromatography using silica gel (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 3[thin space (1/6-em)]:[thin space (1/6-em)]1 v/v).
Dopa-DDMAT. 1H NMR (600 MHz, CDCl3) δ (ppm): 0.89 (t, J = 7.0 Hz, 3H, CH3CH2CH2), 1.23–1.32 (m, 16H, CH3(CH2)8CH2), 1.36–1.41 (m, 2H, CH2(CH2)2S), 1.66 (s, 8H, CH2CH2S, C(CH3)2), 2.67 (t, J = 7.0 Hz, 2H, CH2–ArC), 3.26 (t, J = 7.6 Hz, 2H, CH2CH2S), 3.41–3.49 (m, 2H, NHCH2CH2), 6.56 (dd, J = 8.0, 2.2 Hz, 1H, ArC–H(m-OH)), 6.64 (t, J = 5.5 Hz, 1H, NHCH2CH2), 6.71 (d, J = 2.0 Hz, 1H, ArC–H(o-OH)), 6.80 (d, J = 8.2 Hz, 1H, ArC–H(o-OH)); 13C NMR (100 MHz, CDCl3) δ (ppm): 14.1 (CH3CH2CH2), 22.7 (CH3CH2CH2), 25.8 (C(CH3)2), 27.7 (CH2CH2S), 29.0 (CH2(CH2)2S), 29.1 (CH2(CH2)3S), 29.3 (CH2(CH2)4S), 29.4 (CH3(CH2)2CH2), 29.5 (CH3(CH2)3CH2), 29.6 (CH3(CH2)4(CH2)2), 31.9 (CH3CH2CH2), 34.5 (NHCH2CH2), 37.2 (CH2CH2S), 41.7 (NHCH2CH2), 57.1 (C(CH3)2), 115.2 (ArC–H(o-OH)), 115.4 (ArC–H(o-OH)), 120.8 (ArC–H(m-OH)), 130.8 (CH2–ArC), 142.9 (ArC–OH), 144.0 (ArC–OH), 173.2 (CC([double bond, length as m-dash]O)NH), 219.9 (SC([double bond, length as m-dash]S)S). FTIR (cm−1): 3340 (νNH, amide), 3186 (νOH, phenol), 2920 (νasCH2), 2850 (νsCH2), 1622 and 1604 (νC[double bond, length as m-dash]O, amide I & νC[double bond, length as m-dash]C, aromatic), 1531 (νC–N & δNH, amide II), 1447, 1361, 1291, 1252, 1158, 1112, 1072 (νC[double bond, length as m-dash]S), 813 (νasS–C–S).
Dopa-DoPAT. 1H NMR (600 MHz, CDCl3) δ (ppm): 0.89 (t, J = 7.0 Hz, 3H, CH3CH2CH2), 1.21–1.35 (m, 16H, CH3(CH2)8CH2), 1.37–1.45 (m, 2H, CH2(CH2)2S), 1.55 (d, J = 7.6 Hz, 3H, CH(CH3)), 1.71 (quin, J = 7.5 Hz, 2H, CH2CH2S), 2.66 (t, J = 6.8 Hz, 2H, CH2–ArC), 3.28–3.49 (m, 4H, CH2CH2S, NHCH2CH2), 4.69 (q, J = 7.6 Hz, 1H, CH(CH3)), 6.50 (t, J = 5.6 Hz, 1H, NHCH2CH2), 6.57 (dd, J = 7.9, 2.1 Hz, 1H, ArC–H(m-OH)), 6.67 (d, J = 1.8 Hz, 1H, ArC–H(o-OH)), 6.80 (d, J = 8.2 Hz, 1H, ArC–H(o-OH)); 1H NMR (600 MHz, DMSO-d6) δ (ppm): 0.83 (t, J = 6.8 Hz, 3H, CH3CH2CH2), 1.16–1.27 (m, 16H, CH3(CH2)8CH2), 1.28–1.35 (m, 2H, CH2(CH2)2S), 1.42 (d, J = 7.0 Hz, 3H, CH(CH3)), 1.60 (quin, J = 7.5 Hz, 2H, CH2CH2S), 2.48 (m, 2H, CH2–ArC), 3.10–3.22 (m, 2H, NHCH2CH2), 3.33 (t, J = 7.6 Hz, 2H, CH2CH2S), 4.64 (q, J = 7.0 Hz, 1H, CH(CH3)), 6.39 (dd, J = 7.9, 2.1 Hz, 1H, ArC–H(m-OH)), 6.54 (d, J = 2.4 Hz, 1H, ArC–H(o-OH)), 6.59 (d, J = 7.6 Hz, 1H, ArC–H(o-OH)); 8.60 (s) & 8.69 (s) (2H, Ar–OH), 8.31 (t, J = 5.6 Hz, 1H, NHCH2CH2); 13C NMR (100 MHz, CDCl3) δ (ppm): 14.1 (CH3CH2CH2), 16.1 (CH(CH3)), 22.7 (CH3CH2CH2), 27.8 (CH2CH2S), 28.9 (CH2(CH2)2S), 29.1 (CH2(CH2)3S), 29.3 (CH2(CH2)4S), 29.4 (CH3(CH2)2CH2), 29.5 (CH3(CH2)3CH2), 29.6 (CH3(CH2)4(CH2)2), 31.9 (CH3CH2CH2), 34.6 (NHCH2CH2), 37.7 (CH2CH2S), 41.3 (NHCH2CH2), 47.8 (CH(CH3)), 115.3 (ArC–H(o-OH)), 115.5 (ArC–H(o-OH)), 120.7 (ArC–H(m-OH)), 130.4 (CH2–ArC), 142.9 (ArC–OH), 144.0 (ArC–OH), 171.4 (CHC([double bond, length as m-dash]O)NH), 223.4 (SC([double bond, length as m-dash]S)S). FTIR (cm−1): 3341 (νNH, amide), 3238 (νOH, phenol), 2922 (νasCH2), 2848 (νsCH2), 1633 and 1616 (νC[double bond, length as m-dash]O, amide I & νC[double bond, length as m-dash]C, aromatic), 1522 (νC–N & δNH, amide II), 1465, 1365, 1281, 1193, 1070 (νC[double bond, length as m-dash]S), 813 (νasS–C–S).
Dopa-CDSPA. 1H NMR (600 MHz, CDCl3) δ (ppm): 0.89 (t, J = 6.8 Hz, 3H, CH3CH2CH2), 1.22–1.34 (m, 16H, CH3(CH2)8CH2), 1.35–1.45 (m, 2H, CH2(CH2)2S), 1.69 (quint, J = 7.5 Hz, 2H, CH2CH2S), 1.88 (s, 3H, C(CH3)), 2.32–2.39 (m, 1H, CH2aCH2C([double bond, length as m-dash]O)), 2.42–2.47 (m, 2H, CH2CH2C([double bond, length as m-dash]O)), 2.48–2.55 (m, 1H, CH2bCH2C([double bond, length as m-dash]O)), 2.71 (t, J = 7.0 Hz, 2H, CH2[double bond, length as m-dash]ArC), 3.33 (t, J = 7.5 Hz, 2H, CH2CH2S), 3.43–3.54 (m, 2H, NHCH2CH2), 5.63 (t, J = 5.9 Hz, 1H, NHCH2CH2), 6.61 (dd, J = 8.2, 1.7 Hz, 1H, ArC–H(m-OH)), 6.72 (d, J = 1.8 Hz, 1H, ArC–H(o-OH)), 6.83 (d, J = 8.2 Hz, 1H, ArC–H(o-OH)); 13C NMR (100 MHz, CDCl3) δ (ppm): 14.1 (CH3CH2CH2), 22.7 (CH3CH2CH2), 24.8 (C(CH3)), 27.7 (CH2CH2S), 29.0 (CH2(CH2)2S), 29.1 (CH2(CH2)3S), 29.3 (CH2(CH2)4S), 29.4 (CH3(CH2)2CH2), 29.5 (CH3(CH2)3CH2), 29.6 (CH3(CH2)4(CH2)2), 31.9 (CH3CH2CH2, CH2C([double bond, length as m-dash]O)NH), 34.5 (CH2CH2C([double bond, length as m-dash]O)), 34.6 (NHCH2CH2), 37.1 (CH2CH2S), 41.2 (NHCH2CH2), 46.6 ((CH3)C(C[triple bond, length as m-dash]N)), 119.2 (C(C[triple bond, length as m-dash]N)), 115.5 (ArC–H(o-OH)), 115.7 (ArC–H(o-OH)), 120.8 (ArC–H(m-OH)), 130.7 (CH2–ArC), 142.9 (ArC–OH), 144.1 (ArC–OH), 171.4 (CH2C([double bond, length as m-dash]O)NH), 217.2 (SC([double bond, length as m-dash]S)S). FTIR (cm−1): 3286 (overlap: νNH, amide & νOH, phenol), 2919 (νasCH2), 2851 (νsCH2), 2233 (νC[triple bond, length as m-dash]N), 1640 and 1603 (νC[double bond, length as m-dash]O, amide I & νC[double bond, length as m-dash]C, aromatic), 1519 (νC–N & δNH, amide II), 1442, 1360, 1280, 1193, 1151, 1112, 1065 (νC[double bond, length as m-dash]S), 803 (νasS–C–S).

RAFT polymerization of acrylamide

All polymerization experiments were performed at 2 M monomer concentration ([M]0 = 0.049 mol AM) in 24.5 mL DMSO/DMF (97[thin space (1/6-em)]:[thin space (1/6-em)]3, vol%) solvent (vol. of DMF is equivalent to 0.2 AM]0) and 70 °C under argon atmosphere. The DMF was added as an internal reference for the determination of conversion of monomer using subsequent NMR analysis. The initial CTA to initiator ratio ([CTA]0/[I]0 = 5) and the initial monomer to CTA ratio ([M]0/[CTA]0 = 500) were held constant to ensure controlled polymerization. AM (3.554 g, 0.049 mol), ACVA (5.6 mg, 0.0196 mmol), 24.5 mL DMSO/DMF (97[thin space (1/6-em)]:[thin space (1/6-em)]3 vol%) solvent and the catechol-end RAFT agent (0.098 mmol each, 3a–c) were added to a 100 mL two-neck round-bottom flask equipped with a magnetic stirrer, and a reflux condenser was connected to one of its necks. The flask had its other neck sealed with a rubber septum through which its content was purged with argon for 20 min, before immersing the flask into an oil bath for temperature control as the experiment commenced. At predetermined intervals, 2–3 drops of samples were taken for monomer conversion analysis by 1H NMR while aliquot samples were quenched immediately in liquid nitrogen and then purified prior to GPC analysis. The polymer samples were purified by three cycles of precipitating in 20 times acetone and re-dissolving in deionized H2O before freeze-drying to obtain dried polymer. However, for NMR analysis of the structure of the synthesized polymer, further purification via dialysis (3500 MWCO) against distilled water was carried out.

Pre-treatment of γ-Al2O3 NP

Alumina NPs were pretreated by washing with acetone (twice) and immersed in piranha solution for 30 min (96.5% H2SO4 and 30.5% H2O2 (4[thin space (1/6-em)]:[thin space (1/6-em)]1 vol.)) to remove organic contaminants and to enhance the hydroxylation of the NP surface. Then, the NPs were extracted by washing with water and ethanol, and then vacuum dried.

Preparation of γ-Al2O3-PAM nanocomposite (Al-PAM)

Following ultrasonication of the pretreated alumina NP cores (30 mg), a solution containing (5 mg mL−1) of Dopa-PAM (Mn = 26[thin space (1/6-em)]500, 42[thin space (1/6-em)]600, 53[thin space (1/6-em)]800 g mol−1; synthesized from Dopa-CTA (3a)) was dispersed in 15 mL deionized water at 50 °C for 24 h. Then excessive polymer was removed via dissolution and centrifugation before freeze-drying to obtain the dried Al-PAM nanocomposites. For preparing the control Al-PAM sample, a similar procedure was employed except that the polymer used was a PAM synthesized with CTA (1a) (without catechol moiety, Mn = 29[thin space (1/6-em)]600 g mol−1).

Results & discussion

Synthesis and characteristics of catechol end group RAFT agents (Dopa-CTAs (3a–c))

Though the carboxyl group of the CTAs (1a–c, Scheme 1) could be employed as anchor, we chose the catechol moiety because of its ability to chelate various metal oxides (HfO2, ZrO2, MnO2, Y2O3, Al2O3, TiO2, Fe2O3),21,37–39 comparatively better pH stability of its complexes,40 and the relatively mild procedure for its ligand exchange process.8,40,41 Since the trithiocarbonate moiety of RAFT agents is known to decompose at elevated temperature,32 Dopa-CTAs (3a–c) were synthesized via amide linkages under mild conditions (Scheme 1).13,42 This approach involved initial coupling of carboxyl CTAs (1a–c) with a better leaving group (NHS) using EDC as the carboxyl activating agent before amidization. NHS esters allow efficient coupling with amines to yield amide bonds.42 The Dopa-CTAs ((3a–c), termed Dopa-DDMAT, Dopa-DoPAT and Dopa-CDSPA respectively) were then prepared by reacting dopamine with NHS-activated esters of the carboxylic RAFT agents (2a–c). The formed compounds (3a–c) were confirmed via 1D (1H and 13C) and 2D (gHSQC) NMR, ATR-FTIR, and UV-vis spectroscopy.

1H NMR spectra of dopamine hydrochloride, DDMAT (1a), Suc-DDMAT (2a), and Dopa-DDMAT (3a) are compared in Fig. 1. The spectra show all the 1H peaks for the four compounds (dopamine HCl, (1a), (2a) and (3a)), except the weak broad carboxylic acid peak which is located at 10.73 ppm (for full spectra of DDMAT (1a), see ESI Fig. S1). With DDMAT (1a) being converted into Suc-DDMAT (2a), this acid peak disappears while a new peak 29, attributed to succinimidyl protons, appears at 2.82 ppm. Further conversion of Suc-DDMAT (2a) into Dopa-DDMAT (3a) was evident by the absence of the peak 29 in the spectrum of Dopa-DDMAT (3a), and the presence of new peaks 17–19, 21, 22, and 25. The peak 17 is the characteristic signal for the secondary amide proton, while peaks 21, 22 and 25 are ascribed to the catechol moiety.13,40,43 It should be noted that the 1H peaks of phenol hydroxyl groups 26 and 27 were absent when using CDCl3 as solvent but would show when using DMSO-d6 as solvent. 13C NMR spectra of dopamine HCl, DDMAT (1a), Suc-DDMAT (2a), and Dopa-DDMAT (3a) are compared in ESI Fig. S2. The synthesized Dopa-DDMAT (3a) was confirmed by the shifting of the 13C carbonyl peak 16 and the presence of new 13C peaks 18–25 which are comparable to those of the dopamine HCl. All the correlation 1H/13C peaks for the synthesized Dopa-DDMAT (3a) are clearly shown in ESI Fig. S3, confirming its peak assignments and molecular structure. Similarly, the conversions of (1b) to (2b) then (3b), (1c) to (2c) and (3c) were also confirmed by their 1H and 13C NMR spectra in (ESI Fig. S4–S7). The synthesized Dopa-CTAs (3a–c) was also confirmed by ATR-FTIR investigation (ESI Fig. S8–S10). Considering the UV wavelength range 320 to 280 nm for qualitative analysis, the trithiocarbonate group on the Dopa-CTAs (3a–c) was confirmed by the presence of a strong absorption peak centred at 308–310 nm (ref. 13) while a shoulder peak at 292–294 nm reveals the chromophoric effect of the 3,4-dihydroxyphenyl substituent (ESI Fig. S11–S13).


image file: c5ra16193b-f1.tif
Fig. 1 1H NMR spectra of (bottom) dopamine hydrochloride, (1a) DDMAT, (2a) Suc-DDMAT, and (3a) Dopa-DDMAT (600 MHz, @25 °C).

Batch RAFT polymerization of the Dopa-CTAs

To investigate the influence of the Dopa-CTAs over the growth of catechol functionalized polyacrylamide (DPAM), RAFT polymerization of acrylamide was carried out with a ratio of [AM]0[thin space (1/6-em)]:[thin space (1/6-em)][Dopa-CTA]0[thin space (1/6-em)]:[thin space (1/6-em)][ACVA]0 = 2500[thin space (1/6-em)]:[thin space (1/6-em)]5[thin space (1/6-em)]:[thin space (1/6-em)]1 at 70 °C for each of the synthesized Dopa-CTAs (3a–c), with the results listed in Table 1. Due to poor noise-to-catechol signal ratios as the DPAM Mw increases, the number-average Mw values via NMR analysis were only determined for 1 h DPAM samples and found to be comparable with GPC measurements (ESI Table S1). The RAFT process was restricted to approximately 10 h, since the cumulative radical activity of ACVA in DMSO is known to drop drastically beyond 10 h.26 As seen in Fig. 2a, the number-average molecular weights (Mn,GPC) of DPAMs (4a–c) synthesized using the three Dopa-CTAs (3a–c) increase with increasing conversion of monomer AM while the dispersities (Đ) are very low, ≤1.21, showing the characteristics of living/controlled polymerization. More so, increased molecular weight was evidenced by the shift in the GPC DRI peaks toward shorter retention times (ESI Fig. S14). Nonetheless, the number-average molecular weights (Mn,GPC) of the DPAM (4a–c) overshoot their predicted values (Mn,theo) with those of Dopa-CDSPA (4c) giving the highest overshoot (Fig. 2a). Similar overshoots have been observed in a number of studies involving polymerization of acrylamide-based monomer mediated with trithiocarbonate RAFT agents,26,32,44 with one of the plausible reasons for such discrepancy as explained by Thomas et al.26 being the limited extent of utilization of the Dopa-CTAs.
Table 1 RAFT polymerization of acrylamide mediated with Dopa-CTAsa
Dopa-CTA (3) Time (min) Conv. (%) Mn,GPC Mn,theb Mw Mw/Mn
a Reaction conditions: [AM]0[thin space (1/6-em)]:[thin space (1/6-em)][Dopa-CTA]0[thin space (1/6-em)]:[thin space (1/6-em)][ACVA]0 = 2500[thin space (1/6-em)]:[thin space (1/6-em)]5[thin space (1/6-em)]:[thin space (1/6-em)]1, solvent = 24.5 mL DMSO/DMF (97[thin space (1/6-em)]:[thin space (1/6-em)]3, vol%), temp. = 70 °C, [AM]0 = 2 M.b Mn,the = AMMW × P × [AM]0/[Dopa-CTA]0 + [Dopa-CTA]MW (where P is AM conversion, P = 1 − [AM]/[AM]0).
(3a) 60 35.6 14[thin space (1/6-em)]800 13[thin space (1/6-em)]200 17[thin space (1/6-em)]600 1.19
120 61.1 26[thin space (1/6-em)]200 22[thin space (1/6-em)]200 27[thin space (1/6-em)]300 1.04
240 83.0 33[thin space (1/6-em)]700 30[thin space (1/6-em)]000 36[thin space (1/6-em)]100 1.07
360 87.5 36[thin space (1/6-em)]300 31[thin space (1/6-em)]000 38[thin space (1/6-em)]900 1.07
630 93.3 40[thin space (1/6-em)]700 33[thin space (1/6-em)]700 42[thin space (1/6-em)]700 1.05
(3b) 60 25.4 13[thin space (1/6-em)]900 9500 16[thin space (1/6-em)]800 1.21
120 51.5 23[thin space (1/6-em)]800 18[thin space (1/6-em)]800 26[thin space (1/6-em)]100 1.10
240 77.3 33[thin space (1/6-em)]100 28[thin space (1/6-em)]000 36[thin space (1/6-em)]500 1.10
360 85.1 38[thin space (1/6-em)]000 30[thin space (1/6-em)]700 42[thin space (1/6-em)]900 1.13
615 89.3 41[thin space (1/6-em)]000 32[thin space (1/6-em)]200 45[thin space (1/6-em)]700 1.12
(3c) 60 19.4 9400 7400 11[thin space (1/6-em)]300 1.21
120 35.6 19[thin space (1/6-em)]600 13[thin space (1/6-em)]200 22[thin space (1/6-em)]100 1.13
240 62.4 33[thin space (1/6-em)]300 22[thin space (1/6-em)]700 36[thin space (1/6-em)]800 1.10
360 72.6 42[thin space (1/6-em)]400 26[thin space (1/6-em)]300 45[thin space (1/6-em)]900 1.08
610 78.3 46[thin space (1/6-em)]300 28[thin space (1/6-em)]400 48[thin space (1/6-em)]500 1.05



image file: c5ra16193b-f2.tif
Fig. 2 RAFT Polymerization of acrylamide mediated with Dopa-CTAs (3a–c) using [M]0[thin space (1/6-em)]:[thin space (1/6-em)][CTA]0[thin space (1/6-em)]:[thin space (1/6-em)][I]0 = 2500[thin space (1/6-em)]:[thin space (1/6-em)]5[thin space (1/6-em)]:[thin space (1/6-em)]1 ([M]0 = 2 M), (a) evolution of molecular weight (Mn) and dispersity with conversion (the theoretical Mn is represented with broken line ---); and (b) pseudo-first order kinetics, where P is AM conversion, P = 1 − [AM]/[AM]0. Note: the theoretical Mn line slightly differs for each polymerization; however the lines overlap due to the insignificant difference in the MW of the Dopa-CTAs (3a–c).

The pseudo first order kinetic plots for AM polymerization using the Dopa-CTAs shown in Fig. 2b deviate from linearity, approaching a polynomial distribution, thereby suggestive of the rate of propagation having non-steady state behaviour. This non-linearity may be explained by the change in cumulative radical production from ACVA in DMSO at 70 °C owing to its decay constant.26 Additional details on the cumulative radical production from ACVA in DMSO solvent as related to its decomposition rate constant at 70 °C can be found in the literature.26 More so, as identified by Moad and Barner-Kowollik,25 the causes of non-steady state polymerization during the RAFT process include changing rate coefficients with chain length, slow fragmentation of RAFT adduct and large disparity in radical addition rates with respect to monomer and CTA. Cognizant of these causes, we dislodged the effect of the latter two by monitoring the rate of propagation after the pre-equilibrium period (i.e. after 1 h, indicative of when the initial Dopa-CTAs had been completely consumed, Fig. 2b) to address the steady state assumption of the propagating radicals [P˙m]. Overall, the Dopa-DDMAT (3a) RAFT agent appears to have the most preferred living characteristics based on its comparatively lower PDI values, better linearity and lower extent of Mn overshoot (Fig. 2). This is expected since the catechol R groups must be good homolytic leaving groups and be capable of re-initiation, with the ease of the former depending on the stability of their corresponding expelled radicals (catechol R group derived).24,45 The expelled radicals for both Dopa-DDMAT (3a) and Dopa-CDSPA (3c) are tertiary, that of Dopa-DDMAT (3a) is stabilized by two methyl groups and an electron donating carbonyl carbon of amide group, while the other (3c derived) is less stabilized owing to the electron withdrawing effect of the cyano group on its radical carbon center (see Scheme 2b). The expelled radical of Dopa-DoPAT (3b) is a secondary radical stabilized by a methyl and an amide carbonyl. Steric effects of the catechol R groups were contributory to the stability of their corresponding expelled radicals.24


image file: c5ra16193b-s2.tif
Scheme 2 (a) RAFT Equilibria. (b) R group radicals of the Dopa-CTAs (3).

Alumina-PAM nanocomposite

The synthesized DPAM (4a) prepared via RAFT polymerization ([AM]0[thin space (1/6-em)]:[thin space (1/6-em)][Dopa-CTA]0[thin space (1/6-em)]:[thin space (1/6-em)][ACVA]0 = 2500[thin space (1/6-em)]:[thin space (1/6-em)]5[thin space (1/6-em)]:[thin space (1/6-em)]1 at 70 °C; duration = 35 min) was characterized with 1D (1H and 13C) and 2D (gHSQC, gHMBC) NMR. For the 1D NMR spectra, see ESI Fig. S15–S16. As shown in Fig. 3 (gHSQC and gHMBC spectra), all the correlation 1H/13C peaks confirm the peak assignments and the molecular structure of the synthesized DPAM (4a). In addition to the major peaks (14, 16, and 17) of the repeating unit of polyacrylamide, a few minor peaks are present in the spectra of DPAM (4a). Peaks 1–12 suggest the presence of the Z′ group (CH3–(CH2)11–) while peaks 19, 22–23, 25–26, and 29 indicate the presence of the corresponding R group. The aromatic peaks 25, 26, and 29 confirm the catechol moiety in the synthesized DPAM. It should be noted that the peak of trithiocarbonate carbon (13) is hardly seen in the 13C and gHMBC spectra in spite of an extremely weak peak at 205 ppm which might be attributed to it. Moreover, although there is no correlation 1H/13C peak of carbon 3 of the Z′ group in the 2D NMR spectra, this carbon peak is clearly seen in the 13C NMR spectrum at 31.9 ppm (ESI Fig. S16). With dopamine group being chemically attached to the end of polyacrylamide chains, it was expected that the catechol moiety could induce chemisorption of the polymer onto the γ-Al2O3 NP via covalent bonding or coordination (mono- or bi-dentate bond).12,22 The catechol group acts as the adhesive moiety for mediating the nanocomposites formation via the “grafting to” approach. The DPAM (4a) was selected for anchoring to the pre-treated γ-Al2O3, since Dopa-DDMAT (3a) appeared to be the most preferred CTAs for mediating AM polymerization based on the estimated Capptr and the polymerization experiments. Fig. 4 shows the ATR-FTIR spectrum of the dried γ-Al2O3-PAM PNC after extensive washing, compared with those of the piranha-treated alumina and DPAM (4a). While there is no significant peak in the spectrum of the piranha-treated γ-Al2O3 in the range of 1000–3500 cm−1, the synthesized DPAM (4a) shows strong amide peaks at 3334 (asymmetric N–H stretching), 3188 (symmetric N–H stretching), 1652 (amide I C[double bond, length as m-dash]O stretching), and 1606 cm−1 (amide II N–H deformation and C–N stretching) in addition to three minor peaks at 2930, 1447, and 1414 cm−1 due to the C–H stretching, CH2 bending, and C–N stretching vibrations, respectively.46 The presence of these amide and C–H peaks in the spectrum of the synthesized Al2O3-PAM PNC indicates successful attachment of the DPAM to the Al2O3 NPs.
image file: c5ra16193b-f3.tif
Fig. 3 2D (a) HSQC and (b) HMBC spectra of the synthesized DPAM (4a) in D2O@ 25 °C. Mn,NMR of DPAM = 9313 g mol−1. * This proton is on the equivalent neighbouring carbon.

image file: c5ra16193b-f4.tif
Fig. 4 ATR-FTIR spectra of piranha-treated alumina (Pir-Al2O3), Al2O3-PAM (5a) and DPAM (4a).

The attachment of DPAM on the surface of γ-Al2O3 NPs was also confirmed by TGA and DLS. Fig. 5a compares the weight loss versus temperature for piranha-treated Al2O3 NPs and Al2O3-PAM nanocomposites prepared using DPAM of different molecular weights and PAM (without catechol moiety, Mn,GPC = 29[thin space (1/6-em)]600 Da) as a control. While the piranha-treated Al2O3 lost 1.7% of weight when being heated to 700 °C, the control sample lost 5.7% of weight, indicating 4% of physically absorbed PAM. The Al2O3-PAM nanocomposites prepared using DPAM of different molecular weights (Mn = 26[thin space (1/6-em)]200, 33[thin space (1/6-em)]700, and 40[thin space (1/6-em)]700 Da) demonstrated significantly high weight losses of 23.0%, 58.9%, and 73.8%, respectively. The higher sensitivity in TGA weight loss with increased MW may be due to the shorter polymer chains having enhanced interactions with the alumina NPs. The hydrodynamic size of the PNCs was assessed using the Z-average hydrodynamic diameter (Dh) instead of average Dh. The Z-average value which is based on cumulant method was used as a criterion for comparison because it is numerically stable and less sensitive to noise compared to average Dh.47 The Z-average Dh values for Pir-Al2O3, Al2O3-PAM (26[thin space (1/6-em)]200 Da), Al2O3-PAM (33[thin space (1/6-em)]700 Da) and Al2O3-PAM (40[thin space (1/6-em)]700 Da) were measured to be 165.8, 216.5, 233.6 and 251.5 nm, respectively, with each having a width parameter ≤0.3 (Fig. 5b). Comparison of the hydrodynamic size and PDI (=(σ/d)2) of the Al2O3-PAM PNCs with the bare Pir-Al2O3 is indicative of good dispersivity of the PNC in water (where, σ = standard deviation, d = average diameter). As expected, the Z-ave size of the Al2O3-PAM increased with the length of the polymer chains.


image file: c5ra16193b-f5.tif
Fig. 5 Piranha-treated alumina and alumina-PAM (5a): (a) thermo-gravimetric analysis, and (b) dynamic light scattering analysis. * γ-Al2O3 chemisorbed with PAM (without catechol moiety, Mn,GPC = 29[thin space (1/6-em)]600 Da).

This study indicates that the catechol end-group CTAs provide a suitable route for end-functionalization of PAM for post-modification chemistry. Furthermore, RAFT agents with R groups bearing catechol polar ends provide good stability for controlled polymerization.

Conclusions

In order to produce stable tethering to metal oxide nanoparticles, three novel catechol end trithiocarbonate CTAs (Dopa-CTAs) which differ in their carbonyl α-substituents were synthesized and their molecular structures were confirmed by NMR, UV-vis and ATR-FTIR. The Dopa-CTAs were all found to mediate homo-polymerization of acrylamide in a controlled and quantitative fashion, and the Dopa-DDMAT was found to be the most preferred based on the livingness characteristics and its structural constituents. As evident from the binding studies with γ-Al2O3 NPs, catechol end-group CTAs provide a suitable route for end-functionalization of PAM to allow post-modification chemistry aimed at synthesizing PNCs.

Acknowledgements

The authors acknowledge Polyanalytik Inc. Ontario for providing the PEO standards used for calibrating the GPC instrument. We also thank Prof. John R. de Bruyn (Western University) and his group for granting us access to use the refractometer in their facility. Funding was provided by Canada's National Science & Engineering Research Council (NSERC) Discovery program.

Notes and references

  1. Y. Wang, Y. Kotsuchibashi, Y. Liu and R. Narain, Langmuir, 2014, 30, 2360–2368 CrossRef CAS PubMed .
  2. S. Ji and J. Y. Walz, J. Phys. Chem. B, 2013, 117, 16602–16609 CrossRef CAS PubMed .
  3. J.-P. O'Shea, G. G. Qiao and G. V. Franks, J. Colloid Interface Sci., 2011, 360, 61–70 CrossRef PubMed .
  4. R. Pamies, K. Zhu, S. Volden, A.-L. Kjoniksen, G. Karlsson, W. R. Glomm and B. Nystrom, J. Phys. Chem. C, 2010, 114, 21960–21968 CAS .
  5. H. Li, Z. Zhou, R. S. Chow and P. Contreras, US Pat., 20120138543, 2012 .
  6. G. Rytwo, R. Lavi, Y. Rytwo, H. Monchase, S. Dultz and T. N. König, Sci. Total Environ., 2013, 442, 134–142 CrossRef CAS PubMed .
  7. S. Wang, M.Sc. thesis, University of Alberta, Canada, 2013 .
  8. B. Hojjati, R. Sui and P. A. Charpentier, Polymer, 2007, 48, 5850–5858 CrossRef CAS .
  9. H. Lee, N. F. Scherer and P. B. Messersmith, Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 12999–13003 CrossRef CAS PubMed .
  10. H. Lee, S. M. Dellatore, W. M. Miller and P. B. Messersmith, Science, 2007, 318, 426–430 CrossRef CAS PubMed .
  11. E. Amstad, T. Gillich, I. Bilecka, M. Textor and E. Reimhult, Nano Lett., 2009, 9, 4042–4048 CrossRef CAS PubMed .
  12. W. O. Yah, H. Xu, H. Soejima, W. Ma, Y. Lvov and A. Takahara, J. Am. Chem. Soc., 2012, 134, 12134–12137 CrossRef CAS PubMed .
  13. C. Zobrist, J. Sobocinski, J. Lyskawa, D. Fournier, V. Miri, M. Traisnel, M. Jimenez and P. Woisel, Macromolecules, 2011, 44, 5883–5892 CrossRef CAS .
  14. P. H. Mutin, G. Guerrero and A. Vioux, J. Mater. Chem., 2005, 15, 3761–3768 RSC .
  15. C. Li and B. C. Benicewicz, J. Polym. Sci., Part A: Polym. Chem., 2005, 43, 1535–1543 CrossRef CAS .
  16. C. Li, J. Han, C. Y. Ryu and B. C. Benicewicz, Macromolecules, 2006, 39, 3175–3183 CrossRef CAS .
  17. C. Yang, R. Jie, L. Jianbo and L. Yan, Mater. Lett., 2010, 64, 1570–1573 CrossRef CAS .
  18. C. Boyer, M. R. Whittaker, V. Bulmus, J. Liu and T. P. Davis, NPG Asia Mater., 2010, 2, 23–30 CrossRef .
  19. B. S. Sumerlin, A. B. Lowe, P. A. Stroud, P. Zhang, M. W. Urban and C. L. McCormick, Langmuir, 2003, 19, 5559–5562 CrossRef CAS .
  20. O. Yilmaz, M. Karesoja, A. C. Adiguzel, G. Zengin and H. Tenhu, J. Polym. Sci. Part A: Polym. Chem., 2014, 52, 1435–1447 CrossRef CAS .
  21. M. B. McBride and L. G. Wesselink, Environ. Sci. Technol., 1988, 22, 703–708 CrossRef CAS .
  22. J. H. Waite and M. L. Tanzer, Science, 1981, 212, 1038–1040 CAS .
  23. J. Krstina, G. Moad, E. Rizzardo, C. L. Winzor, C. T. Berge and M. Fryd, Macromolecules, 1995, 28, 5381–5385 CrossRef CAS .
  24. L. Barner and S. Perrier, in Handbook of RAFT polymerization, ed. C. Barner-Kowollik, Wiley-VCH, Weinheim, 2008, pp. 455–482 Search PubMed .
  25. G. Moad and C. Barner-Kowollik, in Handbook of RAFT polymerization, ed. C. Barner-Kowollik, Wiley-VCH, Weinheim, 2008, pp. 51–104 Search PubMed .
  26. D. B. Thomas, A. J. Convertine, L. J. Myrick, C. W. Scales, A. E. Smith, A. B. Lowe, Y. A. Vasilieva, N. Ayres and C. L. McCormick, Macromolecules, 2004, 37, 8941–8950 CrossRef CAS .
  27. M. Arslan, T. N. Gevrek, J. Lyskawa, S. Szunerits, R. Boukherroub, R. Sanyal, P. Woisel and A. Sanyal, Macromolecules, 2014, 47, 5124–5134 CrossRef CAS .
  28. J. S. Kim, T. G. Kim, W. H. Kong, T. G. Park and Y. S. Nam, Chem. Commun., 2012, 48, 9227–9229 RSC .
  29. Y. Min and P. T. Hammond, Chem. Mater., 2011, 23, 5349–5357 CrossRef CAS .
  30. D. J. Keddie, G. Moad, E. Rizzardo and S. H. Thang, Macromolecules, 2012, 45, 5321–5342 CrossRef CAS .
  31. J. Lee, O. Kim, S. Shim, B. Lee and S. Choe, Macromol. Res., 2005, 13, 236–242 CrossRef CAS .
  32. A. J. Convertine, B. S. Lokitz, A. B. Lowe, C. W. Scales, L. J. Myrick and C. L. McCormick, Macromol. Rapid Commun., 2005, 26, 791–795 CrossRef CAS .
  33. W. Sun, J. Long, Z. Xu and J. H. Masliyah, Langmuir, 2008, 24, 14015–14021 CrossRef CAS PubMed .
  34. W. Y. Yang, J. W. Qian and Z. Q. Shen, J. Colloid Interface Sci., 2004, 273, 400–405 CrossRef CAS PubMed .
  35. A. R. Barron, Dalton Trans., 2014, 43, 8127–8143 RSC .
  36. B. Kasprzyk-Hordern, Adv. Colloid Interface Sci., 2004, 110, 19–48 CrossRef CAS PubMed .
  37. H. Gulley-Stahl, P. A. Hogan, W. L. Schmidt, S. J. Wall, A. Buhrlage and H. A. Bullen, Environ. Sci. Technol., 2010, 44, 4116–4121 CrossRef CAS PubMed .
  38. G. S. Tulevski, Q. Miao, M. Fukuto, R. Abram, B. Ocko, R. Pindak, M. L. Steigerwald, C. R. Kagan and C. Nuckolls, J. Am. Chem. Soc., 2004, 126, 15048–15050 CrossRef CAS PubMed .
  39. V. S. Wilms, H. Bauer, C. Tonhauser, A.-M. Schilmann, M.-C. Müller, W. Tremel and H. Frey, Biomacromolecules, 2013, 14, 193–199 CrossRef CAS PubMed .
  40. H. B. Na, G. Palui, J. T. Rosenberg, X. Ji, S. C. Grant and H. Mattoussi, ACS Nano, 2012, 6, 389–399 CrossRef CAS PubMed .
  41. H. Comas, V. Laporte, F. Borcard, P. Miéville, F. Krauss Juillerat, M. A. Caporini, U. T. Gonzenbach, L. Juillerat-Jeanneret and S. Gerber-Lemaire, ACS Appl. Mater. Interfaces, 2012, 4, 573–576 CAS .
  42. E. Valeur and M. Bradley, Chem. Soc. Rev., 2009, 38, 606–631 RSC .
  43. A. Isakova, P. D. Topham and A. J. Sutherland, Macromolecules, 2014, 47, 2561–2568 CrossRef CAS .
  44. M. Hernandez-Guerrero, E. Min, C. Barner-Kowollik, A. H. E. Muller and M. H. Stenzel, J. Mater. Chem., 2008, 18, 4718–4730 RSC .
  45. M. L. Coote and D. J. Henry, Macromolecules, 2005, 38, 1415–1433 CrossRef CAS .
  46. L. T. Chiem, L. Huynh, J. Ralston and D. A. Beattie, J. Colloid Interface Sci., 2006, 297, 54–61 CrossRef CAS PubMed .
  47. ISO. 22412:2008, Particle size analysisphoton correlation spectroscopy, International Organization for Standardization, Geneva, Switzerland, 2008.

Footnote

Electronic supplementary information (ESI) available: Complementary experimental section, NMR, ATR-FTIR and UV-vis spectra; polymerization kinetic plots; and in situ NMR polymerization spectra. See DOI: 10.1039/c5ra16193b

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.